Clinical trial
A Phase 1 Study of TAS-116 (Pimitespib) in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumor
NCT05245968 is registered in ClinicalTrials.gov with Taiho Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of TAS-116 (Pimitespib) in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumor
- Lead sponsor
- Taiho Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- December 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 78 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.